Cite
HARVARD Citation
Zahir, H. et al. (2022). Effect of Mild and Moderate Hepatic Impairment (Defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics. Journal of clinical pharmacology. pp. 992-1005. [Online].